Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage

被引:87
作者
Luptak, Ivan
Shen, Mei
He, Huamei
Hirshman, Michael F.
Musi, Nicolas
Goodyear, Laurie J.
Yan, Jie
Wakimoto, Hiroko
Morita, Hiroyuki
Arad, Michael
Seidman, Christine E.
Seidman, J. G.
Ingwall, Joanne S.
Balschi, James A.
Tian, Rong
机构
[1] Brigham & Womens Hosp, Div Cardiovasc Med, NMR Lab Cardiovasc Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[3] Joslin Diabet Ctr, Metab Unit, Boston, MA 02215 USA
关键词
D O I
10.1172/JCI30658
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
AMP-activated protein kinase (AMPK) responds to impaired cellular energy status by stimulating substrate metabolism for ATP generation. Mutation of the gamma 2 regulatory subunit of AMPK in humans renders the kinase insensitive to energy status and causes glycogen storage cardiomyopathy via unknown mechanisms. Using transgenic mice expressing one of the mutant gamma 2 subunits (N488I) in the heart, we found that aberrant high activity of AMPK in the absence of energy deficit caused extensive remodeling of the substrate metabolism pathways to accommodate increases in both glucose uptake and fatty acid oxidation in the hearts of gamma 2 mutant mice via distinct, yet synergistic mechanisms resulting in selective fuel storage as glycogen. Increased glucose entry in the gamma 2 mutant mouse hearts was directed through the remodeled metabolic network toward glycogen synthesis and, at a substantially higher glycogen level, recycled through the glycogen pool to enter glycolysis. Thus, the metabolic consequences of chronic activation of AMPK in the absence of energy deficiency is distinct from those previously reported during stress conditions. These findings are of particular importance in considering AMPK as a target for the treatment of metabolic diseases.
引用
收藏
页码:1432 / 1439
页数:8
相关论文
共 50 条
[1]   Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart [J].
Abel, ED ;
Kaulbach, HC ;
Tian, R ;
Hopkins, JCA ;
Duffy, J ;
Doetschman, T ;
Minnemann, T ;
Boers, ME ;
Hadro, E ;
Oberste-Berghaus, C ;
Quist, W ;
Lowell, BB ;
Ingwall, JS ;
Kahn, BB .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (12) :1703-1714
[2]   Increased α2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy [J].
Ahmad, F ;
Arad, M ;
Musi, N ;
He, HM ;
Wolf, C ;
Branco, D ;
Perez-Atayde, AR ;
Stapleton, D ;
Bali, D ;
Xing, YQ ;
Tian, R ;
Goodyear, LJ ;
Berul, CI ;
Ingwall, JS ;
Seidman, CE ;
Seidman, JG .
CIRCULATION, 2005, 112 (20) :3140-3148
[3]   Glycogen storage diseases presenting as hypertrophic cardiomyopathy [J].
Arad, M ;
Maron, BJ ;
Gorham, JM ;
Johnson, WH ;
Saul, JP ;
Perez-Atayde, AR ;
Spirito, P ;
Wright, GB ;
Kanter, RJ ;
Seidman, CE ;
Seidman, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04) :362-372
[4]   Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy [J].
Arad, M ;
Moskowitz, IP ;
Patel, VV ;
Ahmad, F ;
Perez-Atayde, AR ;
Sawyer, DB ;
Walter, M ;
Li, GH ;
Burgon, PG ;
Maguire, CT ;
Stapleton, D ;
Schmitt, JP ;
Guo, XX ;
Pizard, A ;
Kupershmidt, S ;
Roden, DM ;
Berul, CI ;
Seidman, CE ;
Seidman, JG .
CIRCULATION, 2003, 107 (22) :2850-2856
[5]   Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy [J].
Arad, M ;
Benson, DW ;
Perez-Atayde, AR ;
McKenna, WJ ;
Sparks, EA ;
Kanter, RJ ;
McGarry, K ;
Seidman, JG ;
Seidman, CE .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) :357-362
[6]   The 5′-AMP-activated protein kinase γ3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle [J].
Barnes, BR ;
Marklund, S ;
Steiler, TL ;
Walter, M ;
Hjälm, G ;
Amarger, V ;
Mahlapuu, M ;
Leng, Y ;
Johansson, C ;
Galuska, D ;
Lindgren, K ;
Åbrink, M ;
Stapleton, D ;
Zierath, JR ;
Andersson, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) :38441-38447
[7]   Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation [J].
Barre, Laura ;
Richardson, Christine ;
Hirshman, Michael F. ;
Brozinick, Joseph ;
Fiering, Steven ;
Kemp, Bruce E. ;
Goodyear, Laurie J. ;
Witters, Lee A. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (03) :E802-E811
[8]   Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy:: evidence for the central role of energy compromise in disease pathogenesis [J].
Blair, E ;
Redwood, C ;
Ashrafian, H ;
Oliveira, M ;
Broxholme, J ;
Kerr, B ;
Salmon, A ;
Östman-Smith, I ;
Watkins, H .
HUMAN MOLECULAR GENETICS, 2001, 10 (11) :1215-1220
[9]   Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner [J].
Buhl, ES ;
Jessen, N ;
Schmitz, O ;
Pedersen, SB ;
Pedersen, O ;
Holman, GD ;
Lund, S .
DIABETES, 2001, 50 (01) :12-17
[10]   ROLE OF THE AMP-ACTIVATED PROTEIN-KINASE IN THE CELLULAR STRESS-RESPONSE [J].
CORTON, JM ;
GILLESPIE, JG ;
HARDIE, DG .
CURRENT BIOLOGY, 1994, 4 (04) :315-324